Bulletin
Investor Alert

London Markets Open in:

Bio-Techne Corp.

NAS: TECH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 11, 2021, 4:00 p.m.

/zigman2/quotes/203973516/composite

$

415.54

Change

0.00 0.00%

Volume

Volume 1,429

Quotes are delayed by 20 min

/zigman2/quotes/203973516/composite

Previous close

$ 408.23

$ 415.54

Change

+7.31 +1.79%

Day low

Day high

$394.88

$416.14

Open

52 week low

52 week high

$228.67

$444.83

Open

Charles R. Kummeth

Currently, Charles R. Kummeth is President, Chief Executive Officer & Director at Bio-Techne Corp. and Chief Executive Officer for ProteinSimple, Inc., Chief Executive Officer of Research & Diagnostic Systems, Inc. and President & Director at CyVek, Inc. (which are all subsidiaries of Bio-Techne Corp.). Charles R. Kummeth is also on the board of 5 other companies.

In his past career Mr. Kummeth occupied the position of President-Mass Spectrometry & Chromatography at Thermo Fisher Scientific, Inc. and Vice President-Medical Division at 3M Co.

He received an undergraduate degree from the University of North Dakota, a graduate degree from the University of St. Thomas (Minnesota) and an MBA from The Curtis L. Carlson School of Management.

Transactions

Date Shares Transaction Value
02/16/2021 17,428   Derivative/Non-derivative trans. at $411 per share. 7,162,908
02/16/2021 30,000   Derivative/Non-derivative trans. at $94.35 per share. 2,830,500
01/15/2021 20,000   Disposition at $344 per share. 6,880,000
12/07/2020 5,000   Disposition at $308 per share. 1,540,000
11/06/2020 15,375   Derivative/Non-derivative trans. at $302.47 per share. 4,650,477
11/06/2020 25,157   Derivative/Non-derivative trans. at $86.25 per share. 2,169,791
08/09/2020 12,287   Derivative/Non-derivative trans. at $265.76 per share. 3,265,394
08/09/2020 21,291   Derivative/Non-derivative trans. at $0 per share. 0
08/05/2020 8,586   Award at $0 per share. 0
05/26/2020 13,018   Derivative/Non-derivative trans. at $266.4 per share. 3,467,996
05/26/2020 21,159   Derivative/Non-derivative trans. at $86.25 per share. 1,824,963
01/06/2020 10,276   Disposition at $217.28 per share. 2,232,770
01/06/2020 10,276   Derivative/Non-derivative trans. at $67.46 per share. 693,218
01/03/2020 1,741   Disposition at $218.23 per share. 379,939
01/03/2020 6,258   Disposition at $217.37 per share. 1,360,302
01/03/2020 7,999   Derivative/Non-derivative trans. at $67.46 per share. 539,612
01/02/2020 92   Disposition at $221.12 per share. 20,344
01/02/2020 775   Disposition at $220.28 per share. 170,717
01/02/2020 9,245   Disposition at $219.32 per share. 2,027,614
01/02/2020 3,282   Disposition at $218.42 per share. 716,855
01/02/2020 6,449   Disposition at $217.4 per share. 1,402,013
01/02/2020 19,843   Derivative/Non-derivative trans. at $67.46 per share. 1,338,608
12/24/2019 471   Disposition at $222.18 per share. 104,647
12/24/2019 471   Derivative/Non-derivative trans. at $67.46 per share. 31,773
12/23/2019 659   Disposition at $222.08 per share. 146,351
12/23/2019 659   Derivative/Non-derivative trans. at $67.46 per share. 44,456
12/20/2019 5,767   Disposition at $222.06 per share. 1,280,621
12/20/2019 5,767   Disposition at $222.06 per share. 1,280,621
12/20/2019 5,767   Derivative/Non-derivative trans. at $67.46 per share. 389,041
12/20/2019 5,767   Derivative/Non-derivative trans. at $67.46 per share. 389,041
12/10/2019 703   Disposition at $222.01 per share. 156,074
12/10/2019 703   Derivative/Non-derivative trans. at $67.46 per share. 47,424
11/29/2019 100   Disposition at $222.62 per share. 22,262
11/27/2019 11,772   Disposition at $222.12 per share. 2,614,797
11/27/2019 11,772   Derivative/Non-derivative trans. at $67.46 per share. 794,139
09/09/2019 100   Acquisition at $185 per share. 18,500
09/09/2019 100   Acquisition at $185 per share. 18,500
08/19/2019 24,979   Derivative/Non-derivative trans. at $0 per share. 0
08/13/2019 7,410   Derivative/Non-derivative trans. at $67.46 per share. 499,878
08/07/2019 11,291   Award at $0 per share. 0
07/10/2019 494   Disposition at $214.07 per share. 105,751
07/10/2019 9,909   Disposition at $213.32 per share. 2,113,788
07/10/2019 6,566   Disposition at $212.75 per share. 1,396,917
07/10/2019 16,969   Derivative/Non-derivative trans. at $67.46 per share. 1,144,728
07/09/2019 15,037   Disposition at $212.43 per share. 3,194,310
07/09/2019 15,037   Derivative/Non-derivative trans. at $67.46 per share. 1,014,396
07/08/2019 17,994   Disposition at $212.75 per share. 3,828,224
07/08/2019 17,994   Derivative/Non-derivative trans. at $67.46 per share. 1,213,875
08/18/2018 1,338   Derivative/Non-derivative trans. at $180.5 per share. 241,509
08/08/2018 11,279   Award at $0 per share. 0
08/07/2018 1,752   Derivative/Non-derivative trans. at $180.14 per share. 315,606
08/07/2018 6,301   Derivative/Non-derivative trans. at $180.14 per share. 1,135,063
08/07/2018 13,816   Derivative/Non-derivative trans. at $0 per share. 0
06/07/2018 8,000   Disposition at $160 per share. 1,280,000
10/26/2017 14,194   Award at $0 per share. 0
08/12/2017 9,248   Derivative/Non-derivative trans. at $0 per share. 0
08/18/2016 16,653   Award at $0 per share. 0

Officers and Executives

Mr. Charles R. Kummeth
President, Chief Executive Officer & Director
Mr. James T. Hippel
CFO & Principal Accounting Officer
Dr. Robert Monroe
Chief Medical Officer
Mr. Kim Kelderman
President-Diagnostics & Genomics
Ms. Brenda Swierenga Furlow
Secretary, Senior Vice President & General Counsel
Mr. Robert M. Gavin
Senior Vice President-Analytical Systems Division
Mr. Kevin S. Gould
Senior Vice President-Diagnostics Division
Mr. David Clair
Senior Director-Investor Relations
Mr. Struan Robertson
Vice President–Human Resources
Mr. Robert V. Baumgartner
Chairman
Dr. Rupert J. Vessey
Independent Director
Ms. Julie L. Bushman
Independent Director
Dr. Randolph C. Steer
Independent Director
Mr. John L. Higgins
Independent Director
Dr. Roeland Nusse
Independent Director
Dr. Alpna H. Seth
Independent Director
Dr. Joseph D. Keegan
Independent Director
Link to MarketWatch's Slice.